$WPRT

Westport to Issue Q2 2026 Financial Results on August 11, 2026

Westport Fuel Systems Inc. (TSX:WPRT, Nasdaq:WPRT) said it will release Q2 2026 financial results on Aug. 11, 2026 after market close. A conference call and webcast will be held Aug. 12, 2026 at 9:30 a.m. ET. The company will archive the webcast and provide a replay on its investor site.

Original reporting
Published Jul 28, 2026, 11:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 11:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Westport to Issue Q2 2026 Financial Results on August 11, 2026 — source image
Decision brief

The 30-second read

$WPRTNeutralLow
01

Why it matters

The main tradable element is the earnings catalyst timing for WPRT, which can drive options implied volatility and positioning into the Aug. 11 after-close release.

02

Market read

Sets the earnings event window for WPRT but provides no new financial or operational information.

03

What to watch

Actual market reaction will depend on the Q2 print and any guidance, which are not disclosed in this announcement.

Relevance 4/10Novelty 3/10Timing: Aug. 11 after-market-close earnings release window for WPRT

Background

Westport Fuel Systems schedules its Q2 2026 financial results release and the follow-on conference call/webcast.

Company-level read

Ticker impact

$WPRTNeutralHigh confidence
Context

Westport announces it will release Q2 2026 financial results on Aug. 11, 2026 after market close, with a call Aug. 12.

Expected impact

Likely modest pre-earnings positioning and volatility around Aug. 11 after close, but no guidance or numbers are provided here.

Evidence & confidence

The article discloses only the release date/time and webcast details, not any new financial results, guidance, or operational change.

Market effects

Limited read-across to alternative-fuel/low-emissions equipment peers because no new sector data or guidance is included.

Primarily affects North American trading around WPRT’s earnings calendar.

Low, as the disclosure is company-specific scheduling without broader macro or regulatory developments.

Counterpoint

Traders may already have WPRT’s earnings date from prior calendars, making incremental impact small.

Key entities

  • Westport Fuel Systems Inc.

    Announced Q2 2026 financial results release date and related conference call/webcast timing.

Related articles

$WPRTMedAI 8/10

Westport Reports Second Quarter 2026 Financial Results

Westport Fuel Systems (TSX:WPRT/Nasdaq:WPRT) reported Q2 2026 results. Revenue fell to $2.7M from $12.5M year over year, while Cespira’s joint venture revenue rose 125% to drive gross profit improvement of 298%. Westport posted net loss from continuing operations of $11.4M and cash of $23.9M. Westport completed a ~$10M private placement.

$WPRTMed

Westport Announces Closing of US$10 Million Registered Direct Offering and Concurrent Private Placement

Westport Fuel Systems Inc. (TSX:WPRT/Nasdaq:WPRT) said it has closed a US$10 million registered direct offering and concurrent private placement. It sold 1.6 million common shares and 3,254,369 pre-funded warrants at an effective US$2.06 per share/warrant, plus private placement warrants exercisable at US$2.06. Gross proceeds were about US$10 million; net proceeds will fund working capital and general corporate purposes.

$PLTRMed

Give Palantir up to $244m through 2028, says internal Defense Department memo

An internal US Defense Department memo reportedly directs subordinates to buy up to $243.9 million in services from Palantir through March 31, 2027, without competitive bidding, and to identify additional funding for April 1, 2027 to Dec. 31, 2028. The memo cites Palantir support for defense industrial base efficiency and munitions/vehicle delays. Palantir is a public company.

$AVRMedAI 8/10

Anteris Technologies Announces Results for the Second Quarter of 2026

Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) reported Q2 2026 results for the quarter ended June 30, 2026. It said CMS granted Medicare reimbursement eligibility for the PARADIGM Trial, U.S. recruitment began with first patients treated in May 2026, and the trial expanded to multiple regions. Net operating cash outflows were $20.8M; R&D expenses were $23.4M.

$ANGOMed

AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027

AngioDynamics (NASDAQ:ANGO) said MedTech is expected to become a majority of revenue by fiscal 2027, citing Auryon share gains and ongoing AMBITION BTK enrollment. Management expects no Auryon study data in fiscal 2027, discussed possible coronary use, and guided fiscal 2027 gross margin to 54% to 55% and adjusted EBITDA to $13M to $16M.